The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 12, 2016
Filed:
Oct. 12, 2012
Applicants:
Paul J. Hergenrother, Champaign, IL (US);
David A. Boothman, Dallas, TX (US);
Joseph S. Bair, Albany, CA (US);
Rahul Palchaudhuri, Cambridge, MA (US);
Elizabeth I. Parkinson, Champaign, IL (US);
Inventors:
Paul J. Hergenrother, Champaign, IL (US);
David A. Boothman, Dallas, TX (US);
Joseph S. Bair, Albany, CA (US);
Rahul Palchaudhuri, Cambridge, MA (US);
Elizabeth I. Parkinson, Champaign, IL (US);
Assignee:
The Board of Trustees of the University of Illinois, Urbana, IL (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/00 (2006.01); A61K 31/675 (2006.01); C07D 471/04 (2006.01); A61K 31/47 (2006.01); C07H 15/26 (2006.01); C07F 9/6561 (2006.01);
U.S. Cl.
CPC ...
C07D 471/04 (2013.01); A61K 31/47 (2013.01); C07F 9/6561 (2013.01); C07H 15/26 (2013.01);
Abstract
Compounds of Formula (I) can be selectively lethal toward a variety of different cancer cell types. The compounds are useful for the management, treatment, control, or adjunct treatment of diseases, where the selective lethality is beneficial in chemotherapeutic therapy.